C.R. Bard Acquires NeoMend for $165,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cdeb8658-f901-4f6e-97ad-b8c5efd80945&Preview=1 - Date
10/24/2012 - Company Name
NeoMend - Mailing Address
60 Technology Drive Irvine, CA 92618 - Company Description
NeoMend, Inc. is a privately held, clinical stage biomedical device company engaged in the development and commercialization of advanced surgical wound healing products. - Website
http://www.neomend.com - Transaction Type
M&A - Transaction Amount
$165,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
The merger consideration is for a purchase price of $140 million paid at closing and future contingent payments up to an additional $25 million based on specific revenue-based milestones through 2016.
